1 Min Read
** Uranium producer's U.S. listed shares down 4.4 pct at $19.66 in late afternoon trading
** Analysts at Cowen and Co downgrade the stock to "market perform" from "outperform"
** Cut price target to $20 from $25
** "We reassessed our uranium market outlook and expect that a meaningful recovery in pricing will not surface until 2017," the analysts said in a note
** Out of the 13 analysts covering the NYSE-listed stock, nine have a "hold" rating, two have "buy" and two have "strong buy", according to Thomson Reuters data